PureTech Health PLC (PRTC)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
120.00p
Buy
121.20p
-0.40p (-0.33%)
Prices updated at 17 Dec 2025, 16:36 GMT
| Prices minimum 15 mins delay
Prices in GBX
PureTech Health PLC is a cross-disciplinary healthcare company developing products that could improve the lives of patients.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 750,000 | 4m | |
| - | - | |
| -146m | -136m | |
| -19,493.47 | -3,154.00 | |
| -66m | 54m | |
| -18m | 37m | |
| Sales, General and administrative | 25m | 27m |
| Interest expenses | 13m | 10m |
| Provision for income taxes | 31m | -4m |
| Operating expenses | 147m | 140m |
| Income before taxes | -36m | 24m |
| Net income available to common shareholders | -66m | 54m |
| -0.24 | 0.21 | |
| Net interest income | 3m | 13m |
| Advertising and promotion | - | - |
| Net investment income, net | -94,000 | -25,000 |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | -0.24 | 0.21 |
| Free cash flow per share | -0.4412 | -0.3544 |
| Book value/share | 1.4841 | 1.0514 |
| Debt equity ratio | 0.039326 | 0.035377 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 347m | 386m |
| Current liabilities | 51m | 41m |
| Total capital | 464m | 415m |
| Total debt | 25m | 22m |
| Total equity | 464m | 415m |
| Total non current liabilities | - | - |
| Loans | - | - |
| Total assets | 694m | 603m |
| Total liabilities | - | - |
| Cash and cash equivalents | 191m | 281m |
| Common stock | 272m | 239m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 150m | 191m |
| Cash dividends paid | - | - |
| -106m | -134m | |
| Investments (gains) losses | 69m | 241m |
| 191m | 281m | |
| Net income | - | - |
| -106m | -134m | |
| -245,000 | -11,000 |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
